SPY299.08+3.64 1.23%
DIA250.25+5.37 2.19%
IXIC9,340.22+15.63 0.17%

HTG Molecular Diagnostics Q1 EPS $(0.080) Beats $(0.100) Estimate, Sales $2.200M Miss $3.040M Estimate

HTG Molecular Diagnostics (NASDAQ:HTGM) reported quarterly losses of $(0.080) per share which beat the analyst consensus estimate of $(0.100) by 20 percent. This is a 57.89 percent increase over losses of $(0.190) per

Benzinga · 05/13/2020 20:08

HTG Molecular Diagnostics (NASDAQ:HTGM) reported quarterly losses of $(0.080) per share which beat the analyst consensus estimate of $(0.100) by 20 percent. This is a 57.89 percent increase over losses of $(0.190) per share from the same period last year. The company reported quarterly sales of $2.200 million which missed the analyst consensus estimate of $3.040 million by 27.63 percent. This is a 31.31 percent decrease over sales of $3.203 million the same period last year.